Shingles vaccine may lower dementia risk, new study finds

A recent study has found that older adults who receive the shingles vaccine may have a lower risk of developing dementia. The study, published in the Annals of Internal Medicine, focused on elderly nursing home residents who received at least one dose of the Shingrix vaccine, the only shingles vaccine available in the United States. The results showed that those who were vaccinated were 24 percent less likely to develop dementia over a four-year period compared to those who were not vaccinated.

This research adds to the growing body of evidence linking the viral infection of shingles to cognitive decline. Previous studies have also shown a connection between shingles and an increased risk of developing dementia. By getting vaccinated against shingles, older adults may be able to reduce their risk of cognitive decline and potentially lower their chances of developing dementia.

It is important for older adults to consider getting vaccinated against shingles to protect their overall health and well-being. The Shingrix vaccine has been shown to be highly effective in preventing shingles and its complications, including the potential link to cognitive decline. By taking proactive steps to protect against shingles, older adults may be able to lower their risk of developing dementia and maintain their cognitive function as they age.

In conclusion, getting vaccinated against shingles could have significant benefits for older adults, including a lower risk of developing dementia. It is essential for older adults to discuss the shingles vaccine with their healthcare provider and consider the potential impact on their cognitive health. By staying informed and taking preventive measures, older adults can prioritize their overall health and well-being as they age.